{"id":7637,"date":"2018-05-28T00:00:00","date_gmt":"2018-05-27T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2018\/05\/28\/llum-verda-a-remab-la-nova-spin-off-de-lidibell\/"},"modified":"2020-08-07T10:42:12","modified_gmt":"2020-08-07T08:42:12","slug":"llum-verda-a-remab-la-nova-spin-off-de-lidibell","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2018\/05\/llum-verda-a-remab-la-nova-spin-off-de-lidibell\/","title":{"rendered":"Llum verda a REMAB, la nova Spin-Off de l’IDIBELL"},"content":{"rendered":"
REMAB Therapeutics, \u00a0la nova Spin-off de IDIBELL, va finalitzar el proc\u00e9s de constituci\u00f3 oficial a finals del passat mes d’abril de 2018. L’empresa compta amb els doctors Rafael M\u00e1\u00f1ez (IP) i Daniel Bell, pertanyents al grup de recerca en immunitat innata i patologia del pacient cr\u00edtic, com a socis fundadors, juntament amb IDIBELL.<\/p>\n
REMAB t\u00e9 com a principal objectiu del desenvolupament d’una nova mol\u00e8cula per al tractament preventiu d’infeccions nosocomials per bacteris Gram negatiu. El tractament es basa en l’eliminaci\u00f3 sist\u00e8mica d’uns anticossos naturals anomenats “no neutralitzants” que afavoreixen el creixement del patogen, interferint en la resposta natural del sistema immune. Es tracta d’un nou enfocament amb un mecanisme d’acci\u00f3 innovador que obrir\u00e0 una nova visi\u00f3 en la manera de tractar i \/ o prevenir diverses patologies.<\/p>\n
Una Spin off \u00e9s una petita empresa de nova creaci\u00f3, nascuda per al desenvolupament i \/ o explotaci\u00f3 de productes o serveis basats en tecnologies o coneixements que provenen d’activitats de recerca realitzada en un centre o instituci\u00f3 de recerca p\u00fablic o privat. A hores d’ara, REMAB constitueix la setena spin-off creada el IDIBELL, i una de les cinc en actiu. La seva capitalitzaci\u00f3 ha estat possible gr\u00e0cies a la inversi\u00f3 d’\u00e0ngels inversors i l’equip promotor.<\/p>\n","protected":false},"excerpt":{"rendered":"
REMAB Therapeutics, \u00a0la nova Spin-off de IDIBELL, va finalitzar el proc\u00e9s de constituci\u00f3 oficial a finals del passat mes d’abril de 2018. L’empresa compta amb els doctors Rafael M\u00e1\u00f1ez (IP) i Daniel Bell, pertanyents al grup de recerca en immunitat innata i patologia del pacient cr\u00edtic, com a socis fundadors, juntament amb IDIBELL. REMAB t\u00e9 […]<\/p>\n","protected":false},"author":6,"featured_media":10577,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[374,493,334],"tags":[161],"class_list":["post-7637","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-immunitat-innata-i-patologia-del-malalt-critic","category-innovacio","category-medicina-translacional","tag-promocio"],"publishpress_future_action":{"enabled":false,"date":"2024-12-30 05:47:53","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=7637"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7637\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/10577"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=7637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=7637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=7637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}